Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-30 · accession 0001209191-21-054089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-31 | 2021-08-30 | TCRT | Boyle Kevin S. Sr. | CEO, Dir | A - Grant | $0.00 | +875.0K | 875.0K | New | $0 |
| D | 2021-08-31 | 2021-08-30 | TCRT | Boyle Kevin S. Sr. | CEO, Dir | A - Grant | $0.00 | +2.62M | 2.62M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | A | A | 875,000 | $0.00 | 875,000 | D | — | — | (F1) One-fourth of the shares vest on each of August 30, 2022, August 30, 2023, August 30, 2024 and August 30, 2025, subject to the Reporting Person's continued service through each such date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2021-08-30 | A | A | 2,625,000 | $0.00 | 2,625,000 | D | $1.64 · — to 2031-08-29 | 2,625,000 Common Stock | (F2) One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three month after 8/30/2021, subject to the Reporting Person's continued service through each such date. |